应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
已收盘 05-04 16:00:00 EDT
44.39
+0.51
+1.16%
盘后
44.48
+0.09
+0.20%
19:59 EDT
最高
44.58
最低
43.84
成交量
1,868万
今开
44.15
昨收
43.88
日振幅
1.68%
总市值
1,970亿
流通市值
1,415亿
总股本
44.39亿
成交额
8.27亿
换手率
0.59%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和诺德Ozempic口服药即将于5月4日起在美国上市
老虎资讯综合 · 05-01
诺和诺德Ozempic口服药即将于5月4日起在美国上市
美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单,两家药企迎来利好
环球市场播报 · 04-30
美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单,两家药企迎来利好
异动解读 | 诺和诺德盘中大涨5.06%,口服GLP-1药物试验成功及板块联动提振
异动解读 · 04-30
异动解读 | 诺和诺德盘中大涨5.06%,口服GLP-1药物试验成功及板块联动提振
减肥药概念股盘初走强!礼来绩后涨超6%、诺和诺德涨超4%
老虎资讯综合 · 04-30
减肥药概念股盘初走强!礼来绩后涨超6%、诺和诺德涨超4%
财报前瞻|诺和诺德本季度营收预计下滑4.40%,机构观点偏正面
财报Agent · 04-29
财报前瞻|诺和诺德本季度营收预计下滑4.40%,机构观点偏正面
诺和诺德基金会参投的生物科技公司Hemab(COAG.US)拟赴美IPO,最高募资2.12亿美元
智通财经 · 04-28
诺和诺德基金会参投的生物科技公司Hemab(COAG.US)拟赴美IPO,最高募资2.12亿美元
国产司美格鲁肽“首证”缓发?多家申报企业称专利悬崖过后还有数据保护期
智通财经网 · 04-25
国产司美格鲁肽“首证”缓发?多家申报企业称专利悬崖过后还有数据保护期
礼来口服减肥药上市第二周处方量平平,市场热度不及预期
环球市场播报 · 04-25
礼来口服减肥药上市第二周处方量平平,市场热度不及预期
礼来股价跌超4% 诺和诺德涨6%
每日经济新闻 · 04-24
礼来股价跌超4% 诺和诺德涨6%
礼来掉队了?新一代口服减肥药Foundayo开局遇冷,诺和诺德凭借5倍开方量反超
华尔街见闻 · 04-24
礼来掉队了?新一代口服减肥药Foundayo开局遇冷,诺和诺德凭借5倍开方量反超
异动解读 | 口服减肥药处方量远超礼来,诺和诺德盘中大涨5.01%
异动解读 · 04-24
异动解读 | 口服减肥药处方量远超礼来,诺和诺德盘中大涨5.01%
礼来(LLY)减肥药物处方量落后竞品 股价盘前承压
金吾财讯 · 04-24
礼来(LLY)减肥药物处方量落后竞品 股价盘前承压
诺和诺德(NVO.US)口服GLP-1药物青少年试验达主要终点,拟2026年下半年申报新适应症
智通财经 · 04-23
诺和诺德(NVO.US)口服GLP-1药物青少年试验达主要终点,拟2026年下半年申报新适应症
裁员9000人的诺和诺德,又招了2000人
医药之梯 · 04-21
裁员9000人的诺和诺德,又招了2000人
礼来CEO预计:减重药物渗透率峰值或将达到潜在适用人群的半数左右
环球市场播报 · 04-18
礼来CEO预计:减重药物渗透率峰值或将达到潜在适用人群的半数左右
礼来口服减肥药Foundayo上市首周获1390张处方,远低于诺和诺德口服版Wegovy
智通财经 · 04-17
礼来口服减肥药Foundayo上市首周获1390张处方,远低于诺和诺德口服版Wegovy
诺和诺德人员调整持续 新增招聘2000人
环球市场播报 · 04-17
诺和诺德人员调整持续 新增招聘2000人
诺和诺德与OpenAI达成战略合作;再生元牵手Telix
21世纪经济报道 · 04-15
诺和诺德与OpenAI达成战略合作;再生元牵手Telix
诺和诺德全球高级副总裁兼大中国区总裁蔡琰:立足司美原研优势 挑战中寻找更大机遇
21世纪经济报道 · 04-15
诺和诺德全球高级副总裁兼大中国区总裁蔡琰:立足司美原研优势 挑战中寻找更大机遇
诺和诺德(NVO)单剂量7.2毫克司美鲁肽注射笔获英国药品和健康产品管理局批准
金吾财讯 · 04-14
诺和诺德(NVO)单剂量7.2毫克司美鲁肽注射笔获英国药品和健康产品管理局批准
加载更多
公司概况
公司名称:
诺和诺德
所属市场:
NYSE
上市日期:
--
主营业务:
Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司,也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。
发行价格:
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":44.39,"timestamp":1777924800000,"preClose":43.88,"halted":0,"volume":18675603,"hourTrading":{"tag":"盘后","latestPrice":44.48,"preClose":44.39,"latestTime":"19:59 EDT","volume":342109,"amount":15190236.6921,"timestamp":1777939166194,"change":0.09,"changeRate":0.002027,"amplitude":0.008013},"delay":0,"changeRate":0.011622607110300774,"floatShares":3187922885,"shares":4439052849,"eps":3.620568,"marketStatus":"已收盘","change":0.51,"latestTime":"05-04 16:00:00 EDT","open":44.15,"high":44.58,"low":43.843708,"amount":827245415.469339,"amplitude":0.01678,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.620568,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777968000000},"marketStatusCode":5,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":43.88,"dividendRate":0.038791,"preHourTrading":{"tag":"盘前","latestPrice":44.16,"preClose":43.88,"latestTime":"09:29 EDT","volume":1015544,"amount":45059135.839608,"timestamp":1777901399999,"change":0.28,"changeRate":0.006381,"amplitude":0.033728},"postHourTrading":{"tag":"盘后","latestPrice":44.48,"preClose":44.39,"latestTime":"19:59 EDT","volume":342109,"amount":15190236.6921,"timestamp":1777939166194,"change":0.09,"changeRate":0.002027,"amplitude":0.008013},"volumeRatio":0.901692,"optionData":{"bulkOrders":[{"symbol":"NVO","call":true,"expireDate":1789704000000,"strike":"35.0","timestamp":1777912295170,"price":10.85,"volume":1999,"amount":2168915,"type":"+"}]},"impliedVol":0.5433,"impliedVolPercentile":0.6892},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"1144481720","title":"诺和诺德Ozempic口服药即将于5月4日起在美国上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1144481720","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144481720?lang=zh_cn&edition=full","pubTime":"2026-05-01 20:30","pubTimestamp":1777638622,"startTime":"0","endTime":"0","summary":"5月1日,诺和诺德公司正在美国将一种现有的、不太受欢迎的糖尿病药片重新命名为 Ozempic,以期利用全球最畅销药物之一的品牌知名度。今年 2 月,当 Ozempic 药丸获得美国食品药品监督管理局批准时,诺和诺德表示,在美国逐步淘汰 Rybelsus 品牌是合理的。此次推出口服药片,标志着诺和诺德公司旗下的Ozempic产品线不再局限于注射剂。诺和诺德表示,对于大多数有医保的患者来说,Ozempic口服药片的价格可能低至25美元,可供三个月使用。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ec680a2539a9ae8f051490080e2eee7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德Ozempic口服药即将于5月4日起在美国上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","NVO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2631651431","title":"美国FDA提议将诺和诺德、礼来减肥药移出批量配药清单,两家药企迎来利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2631651431","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631651431?lang=zh_cn&edition=full","pubTime":"2026-04-30 23:36","pubTimestamp":1777563360,"startTime":"0","endTime":"0","summary":" 美国食品药品监督管理局提议,将诺和诺德与礼来旗下爆款肥胖及糖尿病药物的活性成分,从外包机构可用于批量配药的药品目录中剔除。 若该提案最终落地,此举将限制这类药物的大规模仿制调配生产;除非相关药品被列入 FDA药品短缺清单,否则不得批量配药。 FDA 在公告中称,目前不存在临床必要性,需要外包机构使用原料药批量调配上述药物。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-30/doc-inhwhzrz7241664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2237443382.USD","LU1868836757.USD","LU0238689110.USD","LU0058720904.USD","LU2265009873.SGD","LU2324357040.USD","LU2417539215.USD","LU2756315318.SGD","SGXZ81514606.USD","IE00BJLML261.HKD","LU2361044865.SGD","LU0882574139.USD","LU2168564149.EUR","LU1868837136.USD","IE0009355771.USD","LU0256863811.USD","LU0786609619.USD","BK4585","LU1804176565.USD","LU2471134879.HKD","LU2552382132.HKD","SGXZ57979304.SGD","LU2111349929.HKD","LU0203202063.USD","LU0466842654.USD","LU1291159041.SGD","LU0079474960.USD","LU2456880835.USD","LU0096364046.USD","BK4533","LU2361044949.HKD","LU0417517546.SGD","LU0385154629.USD","IE00B1BXHZ80.USD","LU2089284900.SGD","LU2108987350.USD","LU1629891620.HKD","LU0106261372.USD","BK4532","LU1868836914.USD","SG9999015986.USD","LU2087625088.SGD","LU0122379950.USD","LU0006306889.USD","SG9999015945.SGD","LU0323591593.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0133085943.USD","IE00BJJMRX11.SGD","BK4599","LU0787776722.HKD","LU1623119135.USD","LU0061475181.USD","LU0823434740.USD","LU0882574055.USD","GB00BDT5M118.USD","LU0158827948.USD","SG9999014880.SGD","LU1069344957.HKD","LU2756315664.SGD","LU0256863902.USD","LU2213496289.HKD","LU0943347566.SGD","LU1814569148.SGD","IE00BFSS8Q28.SGD","LU1023059063.AUD","IE00BJJMRY28.SGD","LU1035775433.USD","SGXZ31699556.SGD","LU0354030438.USD","IE0001KFT4U8.USD","BK4534","IE00BJJMRZ35.SGD","LU2237443465.HKD","LU2357305700.SGD","IE00B4JS1V06.HKD","SGXZ51526630.SGD","LU2360106947.USD","LU1232071149.USD","LU2271345857.HKD","LU1868836591.USD","LU2264538146.SGD","LU1983299246.USD","LU2461242641.AUD","LU0210536198.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0823416689.USD","LU2023250330.USD","LU0109394709.USD","LU1145028129.USD","LU0154236417.USD","LU0683600562.USD","SG9999014914.USD","LLII","LU0689472784.USD","LU1989771016.USD","LU2746668461.USD","LU2237443622.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","LU2491049909.HKD","LU2023251221.USD","LU0889565916.HKD","LU2106854487.HKD","SG9999001176.SGD","LLY","LU1917777945.USD","LU0198837287.USD","LU1974910355.USD","BK4007","IE0004445239.USD","BK4581","LU0094547139.USD","LU0432979614.USD","LU2211815571.USD","SG9999001176.USD","SG9999013999.USD","LU2168564222.USD","LU2896262040.SGD","IE00BK4W5L77.USD","LU2168563687.JPY","IE00BN29S564.USD","LU0114720955.EUR","LU1366192091.USD","LU1868837300.USD","LU2237438978.USD","LU0471298694.HKD","LU0203201768.USD","IE00B7KXQ091.USD","LU2491050071.SGD","LU1988902786.USD","IE00BFSS7M15.SGD","LU1323610961.USD","LLYX","LU2237443895.HKD","LU1061106388.HKD","LU1064131342.USD","LU2471134523.USD","LU2168564495.EUR","LU2471134796.USD","IE0002141913.USD","IE00BWXC8680.SGD","LU0672654240.SGD","LU0823434583.USD","LU2552382058.USD","LU1057294990.SGD","LU1548497426.USD","LU0266013472.USD","LU0097036916.USD","LU2089283258.USD","IE0005OL40V9.USD","BK4588","LU1093756325.SGD","LU2063271972.USD","IE00B775H168.HKD","LU0820561909.HKD","LU2237443978.SGD","LU0109391861.USD","LU2471134952.CNY","LU2462157665.USD","SGXZ99366536.SGD","LU1280957306.USD","LU0354030511.USD","IE00BKDWB100.SGD","LU0456855351.SGD","LU0316494557.USD","LU0320765992.SGD","LU1127390331.HKD","LU2361045086.USD","LU0708995401.HKD","SG9999018865.SGD","LU0225283273.USD","IE00B1XK9C88.USD","LU1093756168.USD","LU2602419157.SGD","BK4516","LU1720051017.SGD","LU2028103732.USD","LU1712237335.SGD","LU0640476718.USD","SG9999018857.SGD","LU1720051108.HKD","SG9999014906.USD","LLYZ","LU0353189763.USD","LU2237443549.SGD","LU0471298777.SGD","LU2089984988.USD","SG9999015952.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","NVOX","LU2491050154.USD","LU0820562030.AUD","SG9999014898.SGD","LU2746668974.SGD","LU2750360997.AUD","LU0964807845.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","NVO","ELIS","LU2236285917.USD","LU0158827781.USD","LU0820561818.USD","LU0353189680.USD","LU1551013342.USD","SG9999017495.SGD","LU2750360641.GBP","IE00BKPKM429.USD","SG9999015978.USD","LU2023250504.SGD","LU2468319806.SGD","NVOH","LU0320765059.SGD","LU1551013425.SGD","LU0234572021.USD","LU2168564065.EUR","IE0004445015.USD","LU2552382215.SGD","ELIL"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1168226841","title":"异动解读 | 诺和诺德盘中大涨5.06%,口服GLP-1药物试验成功及板块联动提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1168226841","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168226841?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:59","pubTimestamp":1777557563,"startTime":"0","endTime":"0","summary":"诺和诺德(NVO)今日盘中股价大幅上涨5.06%,引起了市场的广泛关注。消息面上,公司口服GLP-1药物在青少年临床试验中达到主要终点,并计划于下半年申报新适应症,这标志着其在核心管线口服化方面取得了关键性进展,增强了市场对公司未来增长潜力的信心。此外,公司即将发布新季度财报,市场预期虽营收同比略有下滑,但每股收益预计将微增,机构整体观点偏向正面。同时,同属GLP-1赛道的礼来公司股价亦表现强劲,整个行业情绪偏暖,形成了积极的板块联动效应,共同支撑了诺和诺德的股价表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181299331","title":"减肥药概念股盘初走强!礼来绩后涨超6%、诺和诺德涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181299331","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181299331?lang=zh_cn&edition=full","pubTime":"2026-04-30 21:38","pubTimestamp":1777556283,"startTime":"0","endTime":"0","summary":"4月30日,$礼来(LLY)$盘初涨超6%,第一季度营收高于预期,并上调全年业绩指引;$诺和诺德(NVO)$涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"05f10e32be2e0de74032173fc3b622bb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0323591593.USD","NVOX","LU2237438978.USD","LU0640476718.USD","LU0266013472.USD","LU2063271972.USD","LU2168564065.EUR","LU2357305700.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00BJJMRY28.SGD","LU2087625088.SGD","LU0689472784.USD","IE0009355771.USD","LU0708995401.HKD","LU2896262040.SGD","LU0823434740.USD","IE00BFSS7M15.SGD","LU1720051017.SGD","IE00B2B36J28.USD","LU1023059063.AUD","NVO","LU0320765992.SGD","LU0882574055.USD","LU2112291526.USD","LU2237443895.HKD","IE0005OL40V9.USD","LU0882574139.USD","LU2168564495.EUR","IE00B1BXHZ80.USD","SGXZ99366536.SGD","LU2417539215.USD","LU2106854487.HKD","LU2213496289.HKD","LU2756315664.SGD","LU2108987350.USD","LU1061106388.HKD","SG9999001176.SGD","LU1712237335.SGD","IE00BK4W5L77.USD","LU2265009873.SGD","SGXZ31699556.SGD","BK4599","IE00BJJMRX11.SGD","LU0823434583.USD","LU1988902786.USD","IE00BWXC8680.SGD","LU0006306889.USD","LU2491050154.USD","LU2456880835.USD","SG9999017495.SGD","LU0672654240.SGD","BK4532","LU1868836914.USD","LU2552382132.HKD","LU2471134523.USD","LU2361045086.USD","LU2462157665.USD","SG9999014898.SGD","IE00BKDWB100.SGD","LU0889565916.HKD","BK4581","LU0256863902.USD","LU2552382215.SGD","IE00B1XK9C88.USD","LLII","LU2471134879.HKD","LU2236285917.USD","LU2468319806.SGD","SG9999015986.USD","LU1035775433.USD","LU2023250330.USD","LU1232071149.USD","LU0683600562.USD","LU1069344957.HKD","LU0316494557.USD","LU0097036916.USD","IE00BN29S564.USD","BK4585","LLYX","LU0109394709.USD","LU1280957306.USD","LU0471298694.HKD","LU0353189680.USD","LU0320765059.SGD","SG9999013999.USD","LU0943347566.SGD","ELIL","SG9999014914.USD","LU1989771016.USD","LU0353189763.USD","LU0354030511.USD","LU2089284900.SGD","LU2361044949.HKD","LU0154236417.USD","LU0964807845.USD","LU0234572021.USD","LU1623119135.USD","LU0158827781.USD","IE00BKPKM429.USD","LU2111349929.HKD","IE0004445015.USD","LU0122379950.USD","BK4588","IE00B775H168.HKD","LU2168563687.JPY","LU0417517546.SGD","LU2750360997.AUD","LU2324357040.USD","LU2461242641.AUD","LU2168564222.USD","LU0133085943.USD","LU2361044865.SGD","IE00BK4W5M84.HKD","LU0456855351.SGD","LU1093756325.SGD","LU2471134952.CNY","IE0001KFT4U8.USD","LU0820561909.HKD","LU2746668461.USD","LU1127390331.HKD","SG9999001176.USD","SG9999014880.SGD","LU2756315318.SGD","SGXZ51526630.SGD","LU0109391861.USD","LU0432979614.USD","LU2028103732.USD","SG9999018857.SGD","LU0096364046.USD","LLYZ","LU0256863811.USD","LU1983299246.USD","SG9999015978.USD","BK4534","LU1291159041.SGD","LU0289739699.SGD","LU0225283273.USD","NVOH","IE00B4JS1V06.HKD","LU1804176565.USD","LU1868837136.USD","LU2089283258.USD","LU0198837287.USD","SGXZ57979304.SGD","LU0820561818.USD","LU2237443978.SGD","LU2211815571.USD","LU2491050071.SGD","LU1551013425.SGD","LU2023250504.SGD","SGXZ81514606.USD","LU1868836757.USD","LU1720051108.HKD","LU0238689110.USD","LU1917777945.USD","LU1366192091.USD","LU2491049909.HKD","LU2089984988.USD","SG9999015952.SGD","LU1814569148.SGD","IE00BFSS8Q28.SGD","LU2237443622.USD","LU0094547139.USD","GB00BDT5M118.USD","LU1267930730.SGD","SG9999015945.SGD","IE00BZ1G4Q59.USD","ELIS","LU1868837300.USD","LU0820562030.AUD","LU0158827948.USD","IE00BKVL7J92.USD","LU2023251221.USD","LU2750360641.GBP","LU2552382058.USD","LU0203201768.USD","LU0385154629.USD","SG9999014906.USD","IE0004445239.USD","LU2602419157.SGD","LU0787776722.HKD","LU0466842654.USD","LU1093756168.USD","IE00BJLML261.HKD","LU0061475181.USD","LU2746668974.SGD","LU2471134796.USD","BK4533","LU1548497426.USD","LU1064131342.USD","IE00B4R5TH58.HKD","LU2237443382.USD","LU0079474960.USD","LU0058720904.USD","LU2360106947.USD","LU1323610961.USD","LU1974910355.USD","LU2264538146.SGD","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","LU0354030438.USD","LU0210536198.USD","LU0114720955.EUR","LU0786609619.USD","LU0203202063.USD","LU0823416689.USD","LU0106261372.USD","LU1629891620.HKD","LU2271345857.HKD","SG9999018865.SGD","LU2168564149.EUR","LU1868836591.USD","BK4516","LU1145028129.USD","LU2237443465.HKD","LU2237443549.SGD","BK4007","LU0471298777.SGD","IE00BJJMRZ35.SGD","LU1551013342.USD","LLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153018295","title":"财报前瞻|诺和诺德本季度营收预计下滑4.40%,机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1153018295","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153018295?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:03","pubTimestamp":1777420981,"startTime":"0","endTime":"0","summary":"诺和诺德将于2026年05月06日美国盘前发布新季度财报,市场聚焦GLP-1管线的口服化推进、产能扩张与价格策略对利润率的综合影响。市场一致预期显示,本季度诺和诺德营收预计为746.42亿丹麦克朗,同比下降4.40%;每股收益预计为6.13丹麦克朗,同比微增0.41%;息税前利润预计为344.02亿丹麦克朗,同比下降6.57%;公司层面在上季度并未披露明确财季收入指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻|诺和诺德本季度营收预计下滑4.40%,机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2630437375","title":"诺和诺德基金会参投的生物科技公司Hemab(COAG.US)拟赴美IPO,最高募资2.12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630437375","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630437375?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:00","pubTimestamp":1777363239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,临床阶段生物科技公司Hemab Therapeutics Holdings Inc.正寻求在美国首次公开募股中最高融资2.12亿美元。此次生物科技公司IPO的背景是,投资者对减肥药物开发商Kailera Therapeutics Inc.给予了热烈反响——该公司于本月初上市,募资7.19亿美元,创下2021年以来该行业在美国最大的IPO记录。招股文件还显示,在本次发行前,RA Capital Management的关联实体与诺和诺德基金会分别持有Hemab 18%和15%的股份。截至2025年12月31日,公司持有现金及现金等价物共1.85亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU0154236417.USD","NVOX","NVOH","BK4599","COAG","LU1093756168.USD","NVO","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","BK4581","BK4007","IE00BZ1G4Q59.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630870132","title":"国产司美格鲁肽“首证”缓发?多家申报企业称专利悬崖过后还有数据保护期","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870132","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870132?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:05","pubTimestamp":1777107938,"startTime":"0","endTime":"0","summary":"司美格鲁肽保护期的延长或将导致国产司美的“内卷”进一步加剧。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260425/20260425170827_99857.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260425/20260425170827_99857.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LLY","BK4532","NVOH","IE00BKVL7J92.USD","BK0187","NVO","BK4585","01513","LU1093756325.SGD","LU0154236417.USD","02566","BK0028","BK0188","NVOX","BK1161","000513","IE00BZ1G4Q59.USD","LU1093756168.USD","BK0239","BK4599","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2630223108","title":"礼来口服减肥药上市第二周处方量平平,市场热度不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2630223108","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630223108?lang=zh_cn&edition=full","pubTime":"2026-04-25 03:24","pubTimestamp":1777058640,"startTime":"0","endTime":"0","summary":"礼来公司新推出的口服减肥药Foundayo在上市第二周的处方数据表现温和,未能重现竞争对手诺和诺德口服版Wegovy当年的火爆开局,引发市场对该产品能否在口服减肥药赛道成功追赶的疑虑。这一数字虽较上市首周的1,390张有所增长,但与诺和诺德口服版Wegovy上市第二周的18,410张处方相比差距悬殊。 受此消息影响,礼来股价早盘一度下跌逾5%,收盘跌幅收窄至4%附近;而诺和诺德股价则上涨约6%。 口服减肥药被视为减重市场的下一个重要战场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-25/doc-inhvrxrs2874883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0006306889.USD","LLYZ","SG9999014880.SGD","LU1868836914.USD","IE0005OL40V9.USD","LU2471134879.HKD","LU2750360997.AUD","SG9999014906.USD","IE00BFSS8Q28.SGD","LU0786609619.USD","LU2237443382.USD","LU2089284900.SGD","LU2237443549.SGD","LU1868837136.USD","LU2023250330.USD","LU0106261372.USD","LU0787776722.HKD","LU2168564222.USD","LU1804176565.USD","LU2213496289.HKD","LU0097036916.USD","LU0225283273.USD","LU1127390331.HKD","LU1868836591.USD","LU1988902786.USD","LU2361044865.SGD","LU2471134952.CNY","LU2461242641.AUD","LU0109394709.USD","LU2417539215.USD","SGXZ57979304.SGD","IE00BJLML261.HKD","LU0823434583.USD","IE00B775H168.HKD","LU2023250504.SGD","LU2087625088.SGD","NVO","BK4533","IE0001KFT4U8.USD","LLII","LU0320765059.SGD","LU0353189763.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU0266013472.USD","IE00B2B36J28.USD","LU2237443895.HKD","BK4581","LU0203201768.USD","LU1983299246.USD","LU2491049909.HKD","LU2746668974.SGD","LU0689472784.USD","LU2237443622.USD","SG9999001176.SGD","LLY","LU2750360641.GBP","IE00B4JS1V06.HKD","LU2896262040.SGD","LU0943347566.SGD","LU2468319806.SGD","LU2756315318.SGD","LU2361045086.USD","LU0133085943.USD","ELIS","LU1035775433.USD","LU0820561909.HKD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","LU2028103732.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU2168564149.EUR","IE00B7KXQ091.USD","LU0109391861.USD","LU1868836757.USD","LU0432979614.USD","LU1064131342.USD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU2108987350.USD","IE00BK4W5M84.HKD","BK4516","LU2211815571.USD","LU1974910355.USD","LU0417517546.SGD","LU1548497426.USD","LU0094547139.USD","LU0256863902.USD","LU2237438978.USD","LU0456855351.SGD","SG9999013999.USD","SG9999015952.SGD","LU0882574139.USD","LU0058720904.USD","LU1623119135.USD","LU2491050154.USD","SG9999017495.SGD","LU0122379950.USD","LU1551013425.SGD","SG9999015945.SGD","BK4588","LU0820562030.AUD","LU1868837300.USD","LU2168564065.EUR","LU0316494557.USD","LU2324357040.USD","LU0158827781.USD","IE00BK4W5L77.USD","LU0823416689.USD","SGXZ51526630.SGD","LU0210536198.USD","LU0820561818.USD","IE00BN29S564.USD","SG9999014914.USD","IE00B4R5TH58.HKD","LLYX","LU2168563687.JPY","BK4007","LU2237443978.SGD","IE0002141913.USD","LU2106854487.HKD","SG9999014898.SGD","IE00BKDWB100.SGD","LU1629891620.HKD","LU0234572021.USD","ELIL","LU2471134523.USD","LU1093756168.USD","LU2552382058.USD","LU0158827948.USD","LU1551013342.USD","LU0203202063.USD","LU0079474960.USD","LU1061106388.HKD","LU1720051108.HKD","LU1989771016.USD","LU2112291526.USD","IE00BWXC8680.SGD","LU1720051017.SGD","LU1712237335.SGD","LU0256863811.USD","LU1069344957.HKD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU2361044949.HKD","LU1291159041.SGD","LU2456880835.USD","LU0683600562.USD","IE00BJJMRX11.SGD","LU2265009873.SGD","LU0882574055.USD","BK4599","LU2168564495.EUR","LU0096364046.USD","IE00BKPKM429.USD","LU2360106947.USD","LU0320765992.SGD","LU2552382215.SGD","LU1023059063.AUD","LU0289739699.SGD","LU2237443465.HKD","SG9999001176.USD","LU2271345857.HKD","IE00BFSS7M15.SGD","LU1093756325.SGD","LU1057294990.SGD","GB00BDT5M118.USD","LU1145028129.USD","LU2602419157.SGD","LU0238689110.USD","LU2756315664.SGD","LU0385154629.USD","SGXZ81514606.USD","IE0004445239.USD","LU0323591593.USD","SG9999015978.USD","LU0354030511.USD","LU2111349929.HKD","LU0198837287.USD","LU2552382132.HKD","LU0708995401.HKD","LU2023251221.USD","LU2491050071.SGD","LU0889565916.HKD","LU0466842654.USD","LU0672654240.SGD","LU1917777945.USD","LU2089984988.USD","LU2063271972.USD","LU2357305700.SGD","SG9999015986.USD","SG9999018857.SGD","BK4585","LU0640476718.USD","LU0964807845.USD","LU2471134796.USD","SG9999018865.SGD","LU1232071149.USD","IE0004445015.USD","LU1814569148.SGD","LU1280957306.USD","LU2264538146.SGD","LU1366192091.USD","IE0009355771.USD","IE00B1XK9C88.USD","LU0823434740.USD","LU0471298777.SGD","LU1323610961.USD","LU2089283258.USD","LU1267930730.SGD","LU2746668461.USD","LU0353189680.USD","LU2236285917.USD","LU0471298694.HKD","BK4534"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629828255","title":"礼来股价跌超4% 诺和诺德涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629828255","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629828255?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:35","pubTimestamp":1777041300,"startTime":"0","endTime":"0","summary":"每经AI快讯,4月24日,礼来股价跌4.5%,诺和诺德股价上涨6%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-24/doc-inhvrnzu4489056.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"552b3827e000aa2f07885dba9101e950","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-24/doc-inhvrnzu4489056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0061475181.USD","SGXZ81514606.USD","LU2602419157.SGD","LU1093756168.USD","LU2168564149.EUR","SG9999015978.USD","IE00B775H168.HKD","BK4533","BK4588","BK4581","IE0002141913.USD","LU0786609619.USD","IE0009355771.USD","ELIS","SG9999014898.SGD","LU2264538146.SGD","LU1145028129.USD","LU2552382215.SGD","LU0006306889.USD","LU2112291526.USD","LU2756315318.SGD","LU2087625088.SGD","ELIL","IE0005OL40V9.USD","LU2023250504.SGD","LU2471134952.CNY","LU2237443978.SGD","LU0096364046.USD","LU2552382132.HKD","SG9999013999.USD","SG9999014906.USD","IE00B1BXHZ80.USD","LU0672654240.SGD","LU2111349929.HKD","BK4585","LU1868837136.USD","NVOX","LU2168564222.USD","LU1093756325.SGD","LU1623119135.USD","LU1069344957.HKD","LU1232071149.USD","LU2063271972.USD","LU2237443622.USD","LU2089284900.SGD","SG9999001176.SGD","BK4599","LU0823434740.USD","LU2552382058.USD","LU2168564495.EUR","LU1804176565.USD","IE00BWXC8680.SGD","LU0266013472.USD","LU2106854487.HKD","SG9999015945.SGD","LU1974910355.USD","SG9999015986.USD","LU0353189763.USD","IE00BN29S564.USD","LU0133085943.USD","LU1291159041.SGD","LU2456880835.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU2462157665.USD","LU0225283273.USD","SGXZ51526630.SGD","LU0106261372.USD","SGXZ99366536.SGD","LU1035775433.USD","LU0823416689.USD","LU1868837300.USD","LU0353189680.USD","LU1868836757.USD","LU2211815571.USD","LU2168564065.EUR","LU2756315664.SGD","IE00B4R5TH58.HKD","LU0109391861.USD","IE00BJJMRX11.SGD","BK4532","LU0234572021.USD","LU1917777945.USD","LU2357305700.SGD","LU2750360997.AUD","LU1629891620.HKD","LU1868836591.USD","LU2089283258.USD","LU0964807845.USD","LU1720051108.HKD","LU1551013425.SGD","SG9999018857.SGD","LU2461242641.AUD","LU2324357040.USD","LU1814569148.SGD","LU0471298777.SGD","BK4516","LLYZ","LU0323591593.USD","LU2023251221.USD","SG9999018865.SGD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0154236417.USD","SG9999017495.SGD","IE00BZ1G4Q59.USD","GB00BDT5M118.USD","LU2491050154.USD","LU0683600562.USD","NVO","LU1712237335.SGD","LU0820561909.HKD","LU0210536198.USD","LU0289739699.SGD","IE00B1XK9C88.USD","LU1267930730.SGD","LU0640476718.USD","IE00B2B36J28.USD","LU0238689110.USD","LU2237438978.USD","LU2237443382.USD","LU0943347566.SGD","LU2746668461.USD","LU2108987350.USD","LU0256863902.USD","LU2265009873.SGD","SG9999014914.USD","LU0122379950.USD","LU0158827948.USD","LLYX","LU0708995401.HKD","LU0882574055.USD","LU2750360641.GBP","IE00BK4W5L77.USD","LU2361044949.HKD","LU0466842654.USD","IE00BKVL7J92.USD","LU0198837287.USD","LU0354030511.USD","LU2468319806.SGD","LU1551013342.USD","LU1366192091.USD","BK4534","SG9999014880.SGD","IE00BKPKM429.USD","IE0004445239.USD","LU0097036916.USD","LU2028103732.USD","IE00BFSS7M15.SGD","LU2417539215.USD","LU0385154629.USD","LU1057294990.SGD","LU2471134523.USD","LU0882574139.USD","LU0456855351.SGD","LU2361044865.SGD","LU0787776722.HKD","LU0354030438.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU2023250330.USD","LU0432979614.USD","LU1720051017.SGD","LU2491050071.SGD","LU1323610961.USD","LU1023059063.AUD","BK4007","IE00BJJMRY28.SGD","LU0114720955.EUR","LU0471298694.HKD","LU0889565916.HKD","LU0058720904.USD","LU0094547139.USD","LU2896262040.SGD","LU1280957306.USD","LU2471134879.HKD","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","LU1989771016.USD","LU2746668974.SGD","LU0820562030.AUD","SG9999015952.SGD","LU1988902786.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0417517546.SGD","LU0203202063.USD","LU1983299246.USD","LU2089984988.USD","LU2237443549.SGD","LU2237443895.HKD","LU0689472784.USD","LU2360106947.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU0320765992.SGD","IE00B4JS1V06.HKD","LLII","LU2237443465.HKD","LU2271345857.HKD","LU2471134796.USD","LU1064131342.USD","LU2361045086.USD","LU1127390331.HKD","LU2168563687.JPY","LU0109394709.USD","LLY","LU0158827781.USD","LU0320765059.SGD","LU0823434583.USD","LU0316494557.USD","NVOH","LU1548497426.USD","LU0203201768.USD","LU2213496289.HKD","IE0004445015.USD","SG9999001176.USD","LU0079474960.USD","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842918","title":"礼来掉队了?新一代口服减肥药Foundayo开局遇冷,诺和诺德凭借5倍开方量反超","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842918","media":"华尔街见闻","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629842918?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:15","pubTimestamp":1777040121,"startTime":"0","endTime":"0","summary":"数据显示,Foundayo上市第二周共产生3707张处方,而诺和诺德口服版Wegovy在上市第二周录得18410张处方,差距悬殊。礼来股价盘前大跌8%,诺和诺德股价上涨4%。分析师指出,就口服减肥药而言,诺和诺德或将凭借更具竞争力的产品维持领先地位。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f1ae53e4a6b7139d878341ee022303c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770849","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"礼来掉队了?新一代口服减肥药Foundayo开局遇冷,诺和诺德凭借5倍开方量反超","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","IE00B775H168.HKD","LU2106854487.HKD","LLYZ","LU0225283273.USD","SG9999017495.SGD","SG9999001176.USD","LU1023059063.AUD","LU0158827781.USD","LU2023251221.USD","IE00B7KXQ091.USD","LU1868836914.USD","LU0266013472.USD","LU2213496289.HKD","IE00BFTCPJ56.SGD","LU0820562030.AUD","LU0823434583.USD","LU2168564495.EUR","LU1720051017.SGD","IE00BJLML261.HKD","LU0385154629.USD","LU2111349929.HKD","LU0466842654.USD","LU2750360997.AUD","LU2756315664.SGD","SG9999014906.USD","SGXZ99366536.SGD","LU0820561818.USD","SG9999015978.USD","LU2264538146.SGD","LU2361044865.SGD","LU2023250330.USD","LU0061475181.USD","LU2211815571.USD","LU0823434740.USD","LU2237443465.HKD","LU2168563687.JPY","LU0238689110.USD","LU1291159041.SGD","SGXZ31699556.SGD","SG9999015945.SGD","BK4516","SGXZ81514606.USD","LU2271345857.HKD","LU0210536198.USD","LU0154236417.USD","LU0820561909.HKD","LU1868837136.USD","LU2471134879.HKD","LU0689472784.USD","LLYX","LU1988902786.USD","LU1868836591.USD","LU0320765059.SGD","IE00BJJMRZ35.SGD","LU2471134796.USD","SG9999015952.SGD","LU1868837300.USD","LU0471298694.HKD","LU0417517546.SGD","LU1035775433.USD","LU1804176565.USD","IE00B1XK9C88.USD","LU1232071149.USD","LU1989771016.USD","LU0256863811.USD","IE00BKPKM429.USD","LU0109391861.USD","SGXZ57979304.SGD","LU2236285917.USD","SG9999015986.USD","LU1323610961.USD","LU2237438978.USD","LU0354030511.USD","IE00BK4W5L77.USD","IE0004445239.USD","LU2491050071.SGD","LLY","LU0094547139.USD","SG9999014914.USD","LU2237443978.SGD","LU2552382132.HKD","LU2361045086.USD","LU1548497426.USD","LU2746668974.SGD","LU2237443895.HKD","SG9999018857.SGD","LU0354030438.USD","BK4532","SG9999013999.USD","LU0964807845.USD","BK4007","LU0882574055.USD","IE0001KFT4U8.USD","LU0672654240.SGD","LU1983299246.USD","SG9999018865.SGD","IE00BK4W5M84.HKD","LU2456880835.USD","LU0203201768.USD","ELIS","LU0289739699.SGD","IE0004445015.USD","LU1629891620.HKD","LU2360106947.USD","LU2552382058.USD","IE0009355771.USD","LU1093756168.USD","LLII","LU1127390331.HKD","LU2168564222.USD","LU2023250504.SGD","LU0323591593.USD","LU0198837287.USD","LU2491049909.HKD","LU0432979614.USD","IE00BKDWB100.SGD","LU0708995401.HKD","GB00BDT5M118.USD","LU0786609619.USD","LU1551013342.USD","LU0943347566.SGD","LU2089283258.USD","LU1974910355.USD","LU2357305700.SGD","IE00BFSS7M15.SGD","IE0002141913.USD","LU1868836757.USD","LU1917777945.USD","LU1551013425.SGD","LU2237443622.USD","LU2471134952.CNY","LU2112291526.USD","IE00B4JS1V06.HKD","BK4588","LU0823416689.USD","LU2089984988.USD","LU2324357040.USD","SG9999014898.SGD","LU0316494557.USD","LU1057294990.SGD","LU2087625088.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU2461242641.AUD","LU1064131342.USD","LU1712237335.SGD","LU1069344957.HKD","IE00BJJMRY28.SGD","LU2063271972.USD","BK4533","NVO","LU0353189680.USD","LU2750360641.GBP","IE00BN29S564.USD","LU0122379950.USD","LU2552382215.SGD","LU0683600562.USD","LU1280957306.USD","LU1366192091.USD","LU2089284900.SGD","LU2462157665.USD","LU0889565916.HKD","LU2491050154.USD","LU2896262040.SGD","LU0320765992.SGD","LU2237443549.SGD","LU2468319806.SGD","BK4534","LU0882574139.USD","NVOH","LU1267930730.SGD","LU2168564149.EUR","LU0471298777.SGD","LU0058720904.USD","IE00B1BXHZ80.USD","LU2602419157.SGD","IE00BFSS8Q28.SGD","LU1623119135.USD","LU2168564065.EUR","LU1093756325.SGD","LU2237443382.USD","LU2265009873.SGD","LU0234572021.USD","IE00BJJMRX11.SGD","LU0096364046.USD","BK4585","LU0097036916.USD","LU0640476718.USD","BK4599","LU2108987350.USD","LU2471134523.USD","IE00BJT1NW94.SGD","BK4581","IE00BKVL7J92.USD","LU0079474960.USD","LU0109394709.USD","LU0456855351.SGD","LU2756315318.SGD","LU0256863902.USD","LU1061106388.HKD","LU2417539215.USD","SGXZ51526630.SGD","LU0353189763.USD","NVOX","IE00BWXC8680.SGD","ELIL","IE00B4R5TH58.HKD","LU2361044949.HKD","LU1145028129.USD","LU2746668461.USD","LU0158827948.USD","LU0787776722.HKD","IE0005OL40V9.USD","LU2028103732.USD","LU0006306889.USD","LU1814569148.SGD","LU0203202063.USD","LU1720051108.HKD","LU0133085943.USD","SG9999001176.SGD","SG9999014880.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1167705191","title":"异动解读 | 口服减肥药处方量远超礼来,诺和诺德盘中大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167705191","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167705191?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:57","pubTimestamp":1777039047,"startTime":"0","endTime":"0","summary":"诺和诺德今日盘中大涨5.01%,引起了市场的广泛关注。消息面上,诺和诺德在口服减肥药市场的表现显著优于竞争对手。此外,公司近期推出新平台为自费患者提供减重药物服务,拓宽了商业化渠道,并明确将中国定位为最具战略价值的市场,进一步提振了投资者情绪。分析师指出,口服减肥药被视为减肥医疗领域的新前沿,诺和诺德凭借更具竞争力的产品和先发优势,有望在这一赛道保持领先。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629849265","title":"礼来(LLY)减肥药物处方量落后竞品 股价盘前承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2629849265","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629849265?lang=zh_cn&edition=full","pubTime":"2026-04-24 20:20","pubTimestamp":1777033229,"startTime":"0","endTime":"0","summary":"金吾财讯 | 礼来公司 两款减肥疗法的每周处方量不及诺和诺德竞品Wegovy,受此影响,礼来股价在盘前交易中跌1.82%。分析师指出,截至4月17日当周,礼来Zepbound的总处方量较前一周下降约2%,而同期诺和诺德Wegovy注射剂处方量环比上升7%。礼来新推出的口服减肥药物Foundayo,上市首周处方总量为3707份。分析师表示,不应仅凭单周上市数据评判Foundayo的市场表现,但投资者会密切关注这一处方量差距,这种落差大概率导致礼来当日股价表现疲软。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/MDYxNTA2ZjhkOWVmNGY4NWFiMzk3MGE5NjBhODhjODE3MzYyMzc3Njg0MzY=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDYxNTA2ZjhkOWVmNGY4NWFiMzk3MGE5NjBhODhjODE3MzYyMzc3Njg0MzY=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8f1ae53e4a6b7139d878341ee022303c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299670","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668461.USD","LU0198837287.USD","LU2471134523.USD","LU0122379950.USD","LU0320765059.SGD","IE0004445239.USD","LU2237443978.SGD","LU1551013342.USD","LLYX","BK4007","LU0471298777.SGD","LU1917777945.USD","LU1989771016.USD","LU0158827948.USD","LU1267930730.SGD","LU2552382215.SGD","SG9999014880.SGD","LU1868836914.USD","LU1551013425.SGD","LU1814569148.SGD","LU0106261372.USD","LU0316494557.USD","LU2106854487.HKD","LU0640476718.USD","LU0289739699.SGD","LU0964807845.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","SG9999001176.USD","SG9999001176.SGD","IE00BKPKM429.USD","BK4534","IE00BK4W5L77.USD","LU2361044865.SGD","GB00BDT5M118.USD","LU1988902786.USD","LLY","BK4599","LU1712237335.SGD","IE00BJJMRY28.SGD","LU1061106388.HKD","LU1291159041.SGD","LU2361044949.HKD","IE0009355771.USD","LU0079474960.USD","LU0238689110.USD","ELIS","IE00BWXC8680.SGD","LU2471134879.HKD","LU2491049909.HKD","LU2750360641.GBP","IE00BJJMRZ35.SGD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU2360106947.USD","LU2746668974.SGD","LU0256863811.USD","LU1868837300.USD","LU1280957306.USD","LU0158827781.USD","LU0466842654.USD","IE00BFSS7M15.SGD","LU0385154629.USD","IE00BN29S564.USD","LU2271345857.HKD","LU1720051017.SGD","LU0061475181.USD","LU2168564065.EUR","LU0109391861.USD","LU1035775433.USD","LU2028103732.USD","LU0820561909.HKD","SGXZ31699556.SGD","LU0006306889.USD","LU2357305700.SGD","LU2236285917.USD","LU0417517546.SGD","LU1629891620.HKD","LU1548497426.USD","LU2023250330.USD","IE0002141913.USD","LU2264538146.SGD","SG9999018865.SGD","LU0096364046.USD","LU2237443895.HKD","IE0005OL40V9.USD","LU2089284900.SGD","IE00B1XK9C88.USD","LU2211815571.USD","SG9999014906.USD","LU1023059063.AUD","LU0823434740.USD","LU1868836591.USD","SGXZ51526630.SGD","LLYZ","LU2265009873.SGD","LLII","LU0823416689.USD","LU1093756325.SGD","LU0882574139.USD","LU0266013472.USD","LU1127390331.HKD","LU0320765992.SGD","LU2468319806.SGD","LU2417539215.USD","LU0114720955.EUR","LU0683600562.USD","LU1064131342.USD","BK4533","LU0889565916.HKD","LU2213496289.HKD","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU2552382058.USD","LU1145028129.USD","SGXZ99366536.SGD","LU1232071149.USD","IE0001KFT4U8.USD","LU0353189763.USD","IE00B4R5TH58.HKD","LU0672654240.SGD","LU2168564149.EUR","SG9999014898.SGD","LU2750360997.AUD","LU0058720904.USD","SG9999015986.USD","LU2237438978.USD","LU0234572021.USD","SG9999014914.USD","IE00B1BXHZ80.USD","LU2087625088.SGD","BK4585","LU2108987350.USD","LU2089283258.USD","LU0471298694.HKD","LU2023250504.SGD","LU0943347566.SGD","LU2112291526.USD","SG9999015952.SGD","LU2456880835.USD","LU2491050154.USD","LU0210536198.USD","LU2324357040.USD","SG9999015978.USD","BK4516","LU0203202063.USD","LU0323591593.USD","LU1093756168.USD","LU1868836757.USD","LU2756315664.SGD","LU0456855351.SGD","SGXZ57979304.SGD","LU2756315318.SGD","LU2896262040.SGD","LU0353189680.USD","LU2237443549.SGD","SG9999015945.SGD","LU0708995401.HKD","LU0354030511.USD","BK4588","LU0109394709.USD","LU0689472784.USD","LU1323610961.USD","LU0203201768.USD","LU2168563687.JPY","LU2462157665.USD","LU1983299246.USD","LU1868837136.USD","SG9999013999.USD","LU0354030438.USD","LU1069344957.HKD","IE00B775H168.HKD","LU2237443382.USD","LU0097036916.USD","LU2602419157.SGD","SG9999017495.SGD","LU0133085943.USD","LU2063271972.USD","ELIL","LU2237443622.USD","LU2023251221.USD","IE0004445015.USD","LU0882574055.USD","LU1623119135.USD","NVO","LU0823434583.USD","IE00B7KXQ091.USD","LU0820561818.USD","LU2471134796.USD","LU0432979614.USD","LU1804176565.USD","LU2552382132.HKD","LU2111349929.HKD","IE00BJLML261.HKD","LU1974910355.USD","LU2237443465.HKD","LU0820562030.AUD","LU2461242641.AUD","SG9999018857.SGD","IE00B2B36J28.USD","LU0256863902.USD","LU0786609619.USD","BK4581","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","LU1057294990.SGD","LU2168564495.EUR","LU1366192091.USD","LU2089984988.USD","LU2471134952.CNY","LU0094547139.USD","LU0225283273.USD","LU2168564222.USD","LU2491050071.SGD","IE00BJJMRX11.SGD","SGXZ81514606.USD","LU1720051108.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629301836","title":"诺和诺德(NVO.US)口服GLP-1药物青少年试验达主要终点,拟2026年下半年申报新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2629301836","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629301836?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:41","pubTimestamp":1776944507,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,诺和诺德周四表示,其口服GLP-1药物在2型糖尿病儿童及青少年患者中显著降低了血糖水平,达到了后期试验的主要目标。目前尚无任何口服GLP-1疗法获批用于儿童或青少年,诺和诺德的这款药片有望成为该领域的首个获批产品。该公司计划于2026年下半年向监管部门提交申请,以扩大其口服司美格鲁肽药物Ozempic药丸和Rybelsus在美国及欧盟的适应症范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","BK4532","BK4585","NVO","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","BK4599","BK4144","IE00BZ1G4Q59.USD","NVOH","NVOX","BK4588","LU1093756325.SGD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629036886","title":"裁员9000人的诺和诺德,又招了2000人","url":"https://stock-news.laohu8.com/highlight/detail?id=2629036886","media":"医药之梯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629036886?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:56","pubTimestamp":1776768960,"startTime":"0","endTime":"0","summary":"据彭博社报道,在经历 2025 年的大规模裁员后,丹麦制药巨头诺和诺德 正重塑其人力架构,今年迄今已新增约2000 名员工。据诺和诺德一位发言人表示,这一数字为成功录用的人员数量,其中约 1400 人已入职。诺和诺德2025年全年财务业绩表对于关注医药行业的人而言,诺和诺德 2025 年的销售额或许并不意外。诺和诺和2025年最大的焦点无疑是股价的持续下跌,这一颓势直接引发了管理层更迭。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-04-21/doc-inhvheze6886042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LU0154236417.USD","NVOX","NVOH","BK4599","LU1093756168.USD","NVO","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","IE00BZ1G4Q59.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628878520","title":"礼来CEO预计:减重药物渗透率峰值或将达到潜在适用人群的半数左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2628878520","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628878520?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:33","pubTimestamp":1776447180,"startTime":"0","endTime":"0","summary":"礼来制药首席执行官戴维里克斯周五在一场会议上表示,受医疗体系复杂程度及经济负担能力限制,减重药物最终惠及的超重与肥胖人群,或将仅占潜在适用者的50% 左右。 礼来与其竞争对手诺和诺德,正在全球 GLP-1 类注射及口服减重药市场激烈争夺份额。分析师预计,未来十年该类药物年市场规模将突破1000 亿美元。 里克斯在华盛顿举办的《Semafor 世界经济峰会》上称,目前仅有十分之一的超重及肥胖人群在使用 GLP-1 类药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-18/doc-inhuvvns6177450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999015986.USD","LU0683600562.USD","LU0266013472.USD","LU2746668461.USD","SG9999013999.USD","SGXZ81514606.USD","LU0238689110.USD","LU0466842654.USD","LU0672654240.SGD","LU2106854487.HKD","LU2089284900.SGD","LU2357305700.SGD","LU2324357040.USD","LU0708995401.HKD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU2168563687.JPY","LU2468319806.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LU2750360997.AUD","SG9999015952.SGD","LU0471298777.SGD","SG9999014914.USD","GB00BDT5M118.USD","LU0353189763.USD","BK4585","LU2108987350.USD","LU0203201768.USD","LU2023250330.USD","LU0823434740.USD","LU2361045086.USD","LU0097036916.USD","LU1868836757.USD","LU2063271972.USD","LU1868836591.USD","LU2471134879.HKD","IE0004445239.USD","SG9999014880.SGD","LU1127390331.HKD","LU1868837136.USD","LU0122379950.USD","LU1093756325.SGD","LU1057294990.SGD","LU2462157665.USD","LU1064131342.USD","LU2552382132.HKD","LU0198837287.USD","LU0889565916.HKD","LU1983299246.USD","IE00BJLML261.HKD","LU0316494557.USD","LU2265009873.SGD","BK4534","LU0061475181.USD","IE00BWXC8680.SGD","BK4581","LU0640476718.USD","LU0320765992.SGD","LU2271345857.HKD","LU0114720955.EUR","LU2750360641.GBP","LU2264538146.SGD","LU2471134952.CNY","LU2360106947.USD","LU1629891620.HKD","LU2471134523.USD","LU2211815571.USD","LU0210536198.USD","LU2237443978.SGD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU2236285917.USD","LU2491049909.HKD","LU1917777945.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0432979614.USD","LU1804176565.USD","LU2112291526.USD","BK4599","LU2361044949.HKD","LU2471134796.USD","LU2491050154.USD","LU1069344957.HKD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","IE00BN29S564.USD","LU0354030511.USD","LU1712237335.SGD","LU2089283258.USD","LU0417517546.SGD","SG9999014906.USD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0109394709.USD","SG9999014898.SGD","LU1093756168.USD","LU0823434583.USD","LU0109391861.USD","IE00BJJMRY28.SGD","IE00BK4W5M84.HKD","LU1232071149.USD","BK4516","LLY","LU0256863811.USD","LLYX","LU0820562030.AUD","LU2023251221.USD","LU1814569148.SGD","SG9999018865.SGD","IE0009355771.USD","LU1623119135.USD","LU0234572021.USD","LU0094547139.USD","LU2361044865.SGD","LU2168564495.EUR","LU0353189680.USD","LU1145028129.USD","LU0787776722.HKD","LU1366192091.USD","LU2111349929.HKD","IE00BFTCPJ56.SGD","LU0385154629.USD","SG9999018857.SGD","LU2237443895.HKD","LU0203202063.USD","LU1989771016.USD","LU0943347566.SGD","LU0133085943.USD","LU1868837300.USD","IE00BKPKM429.USD","LU2168564065.EUR","LU0823416689.USD","LU0456855351.SGD","BK4588","LU0320765059.SGD","LU1551013425.SGD","SG9999017495.SGD","IE0004445015.USD","SG9999015978.USD","LU2756315318.SGD","LU0820561818.USD","LU2168564149.EUR","BK4007","LU1035775433.USD","LU0786609619.USD","LU0225283273.USD","LLII","SGXZ31699556.SGD","IE00BJT1NW94.SGD","IE00BKDWB100.SGD","LU1720051108.HKD","LU2602419157.SGD","LU1548497426.USD","LU2456880835.USD","LU0158827948.USD","SGXZ57979304.SGD","IE0005OL40V9.USD","SG9999001176.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU2168564222.USD","IE00B1BXHZ80.USD","LU2087625088.SGD","LU2023250504.SGD","IE0002141913.USD","LU2491050071.SGD","LU2896262040.SGD","LU0096364046.USD","LU0323591593.USD","LU1023059063.AUD","LU2237443465.HKD","NVO","LU1061106388.HKD","LU2461242641.AUD","LU2417539215.USD","LU0256863902.USD","LU1974910355.USD","LU1988902786.USD","LU2552382058.USD","LU0820561909.HKD","LU0158827781.USD","LU0006306889.USD","LU1280957306.USD","LU2237443622.USD","LU0882574139.USD","IE00B2B36J28.USD","LU0354030438.USD","LU0058720904.USD","LU0471298694.HKD","LU2089984988.USD","LU2746668974.SGD","SGXZ99366536.SGD","LU1868836914.USD","IE00B775H168.HKD","ELIS","LU1551013342.USD","LLYZ","LU0689472784.USD","BK4533","SG9999015945.SGD","LU0289739699.SGD","LU2552382215.SGD","LU0964807845.USD","LU2213496289.HKD","LU2237438978.USD","ELIL","IE00B4JS1V06.HKD","SGXZ51526630.SGD","LU1267930730.SGD","LU2237443549.SGD","LU0079474960.USD","LU2028103732.USD","IE00B7KXQ091.USD","LU0882574055.USD","LU1291159041.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2628209656","title":"礼来口服减肥药Foundayo上市首周获1390张处方,远低于诺和诺德口服版Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2628209656","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628209656?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:47","pubTimestamp":1776430064,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,IQVIA的数据显示,截至4月10日当周,礼来新推出的口服减肥药Foundayo在美国获得1390张处方。投资者一直在密切关注相关数据,因为礼来与诺和诺德在减肥药市场的竞争愈发激烈。据悉,Foundayo于4月1日获得批准。礼来在公告中表示,该药片每日服用一次,于4月6日开始发货。试验结果显示,注射形式的减肥药在疗效上仍是“金标准”,但礼来和诺和诺德都已向药片剂型倾斜。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"612f5bda7f3419958510b25465e0ddba","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430181.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"礼来口服减肥药Foundayo上市首周获1390张处方,远低于诺和诺德口服版Wegovy","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756325.SGD","LU1917777945.USD","IE00BKPKM429.USD","LU2456880835.USD","LU2750360997.AUD","LU1868836591.USD","LU0708995401.HKD","SG9999014898.SGD","LU1064131342.USD","LU2461242641.AUD","IE0001KFT4U8.USD","NVOH","LU2361045086.USD","LU1366192091.USD","LU0109391861.USD","LU2265009873.SGD","LU2468319806.SGD","LLYZ","LU2237443622.USD","LU2896262040.SGD","LU0466842654.USD","LU2168564222.USD","LU1035775433.USD","LU2491049909.HKD","SG9999001176.SGD","SGXZ81514606.USD","SG9999014906.USD","LU2750360641.GBP","BK4532","LU0672654240.SGD","LU0943347566.SGD","LU2462157665.USD","LU1145028129.USD","LU2552382215.SGD","LU0210536198.USD","BK4516","LU2168564495.EUR","LU1868836914.USD","LU2237443465.HKD","LU0289739699.SGD","LU1023059063.AUD","LU0061475181.USD","IE0004445015.USD","LU2106854487.HKD","LU0882574139.USD","LU2089284900.SGD","LU0234572021.USD","LU0820562030.AUD","SG9999018865.SGD","LU0006306889.USD","LU0198837287.USD","LU2471134879.HKD","LU2746668461.USD","SG9999014880.SGD","BK4533","LU1814569148.SGD","SG9999013999.USD","SGXZ31699556.SGD","LU1127390331.HKD","LU0823434583.USD","LU0256863811.USD","LU2168564149.EUR","SG9999014914.USD","BK4588","ELIS","LU2087625088.SGD","LU2089984988.USD","LU2756315318.SGD","IE00BZ1G4Q59.USD","LU2108987350.USD","IE00B7KXQ091.USD","LU2237443549.SGD","LU1280957306.USD","LU1983299246.USD","LU2756315664.SGD","LU0266013472.USD","LU0256863902.USD","LU1267930730.SGD","LLY","IE00BJJMRY28.SGD","LU2236285917.USD","LU0354030438.USD","SG9999015986.USD","LU1974910355.USD","LU0203201768.USD","BK4599","LU1988902786.USD","LU0471298777.SGD","LU1868836757.USD","LU0787776722.HKD","BK4585","LU1989771016.USD","LU0106261372.USD","LU2360106947.USD","LU1868837300.USD","IE00B1XK9C88.USD","LU2237443382.USD","IE0009355771.USD","SG9999015952.SGD","LU0158827781.USD","LU0820561909.HKD","LU0353189680.USD","LU2237443978.SGD","IE00BJJMRX11.SGD","LU0471298694.HKD","LLII","LU0154236417.USD","LU0683600562.USD","LU1720051017.SGD","LU2063271972.USD","IE00BKVL7J92.USD","SGXZ51526630.SGD","LU2602419157.SGD","BK4534","LU0320765059.SGD","SG9999001176.USD","LU1291159041.SGD","LU2471134796.USD","IE00B1BXHZ80.USD","LLYX","LU0225283273.USD","IE00BJJMRZ35.SGD","LU0158827948.USD","LU0417517546.SGD","LU0823434740.USD","LU2471134523.USD","LU0964807845.USD","LU0889565916.HKD","LU0640476718.USD","LU0786609619.USD","LU2324357040.USD","LU0203202063.USD","IE00B4JS1V06.HKD","LU2089283258.USD","IE00BFSS7M15.SGD","LU2023251221.USD","LU1551013342.USD","NVOX","LU2417539215.USD","LU1323610961.USD","LU2491050071.SGD","LU0385154629.USD","LU2237443895.HKD","ELIL","LU0320765992.SGD","LU2471134952.CNY","SG9999018857.SGD","LU0096364046.USD","LU1712237335.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0353189763.USD","LU1720051108.HKD","IE00BWXC8680.SGD","LU0820561818.USD","LU2112291526.USD","LU0133085943.USD","IE00B4R5TH58.HKD","LU0323591593.USD","IE00BJLML261.HKD","SG9999015945.SGD","SG9999017495.SGD","IE0002141913.USD","LU2491050154.USD","LU2264538146.SGD","IE0005OL40V9.USD","LU0316494557.USD","LU0354030511.USD","LU0122379950.USD","IE00BKDWB100.SGD","LU1551013425.SGD","SGXZ57979304.SGD","IE0004445239.USD","LU2552382058.USD","LU1093756168.USD","LU1629891620.HKD","LU2111349929.HKD","LU0094547139.USD","LU2168564065.EUR","LU2023250330.USD","LU1868837136.USD","LU2271345857.HKD","SGXZ99366536.SGD","LU2211815571.USD","LU2028103732.USD","IE00BK4W5L77.USD","LU0882574055.USD","LU2361044949.HKD","LU2746668974.SGD","IE00BK4W5M84.HKD","GB00BDT5M118.USD","IE00BJT1NW94.SGD","LU1623119135.USD","LU1069344957.HKD","LU1061106388.HKD","IE00BN29S564.USD","LU2023250504.SGD","LU2213496289.HKD","LU2552382132.HKD","LU2237438978.USD","LU1548497426.USD","LU0823416689.USD","LU0109394709.USD","LU0097036916.USD","IE00BFSS8Q28.SGD","LU2361044865.SGD","NVO","LU0689472784.USD","LU1232071149.USD","IE00B775H168.HKD","LU1804176565.USD","SG9999015978.USD","LU0432979614.USD","LU0114720955.EUR","BK4581","LU0456855351.SGD","LU0238689110.USD","LU2357305700.SGD","LU0079474960.USD","IE00B2B36J28.USD","BK4007","LU2168563687.JPY","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628324530","title":"诺和诺德人员调整持续 新增招聘2000人","url":"https://stock-news.laohu8.com/highlight/detail?id=2628324530","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628324530?lang=zh_cn&edition=full","pubTime":"2026-04-17 03:06","pubTimestamp":1776366360,"startTime":"0","endTime":"0","summary":"诺德诺德在经历了一次相当大规模的人员重组之后,今年正在重新招人,新增约2000名员工。据报道,这些新员工中约有1400人已经入职,其中近400人在丹麦。与此同时,离职仍在发生。诺和诺德的员工自愿离职率为5%,而2025年的总流失率接近18%。在新任首席执行官Mike Doustdar领导的大规模重组中,公司裁减了约7800个职位,约占其员工总数的10%,2025年年底的员工总数约为69505人。此次裁员的影响范围并不局限于基层,也波及了高级管理层,足见变革之深。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-17/doc-inhutspq2543883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LU0154236417.USD","BK4599","IE00BZ1G4Q59.USD","NVOX","NVO","IE00BKVL7J92.USD","BK4007","LU1093756168.USD","BK4532","BK4585","NVOH","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045478","title":"诺和诺德与OpenAI达成战略合作;再生元牵手Telix","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045478","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627045478?lang=zh_cn&edition=full","pubTime":"2026-04-15 08:01","pubTimestamp":1776211308,"startTime":"0","endTime":"0","summary":"政策动向国家医疗保障局持续开展定点医药机构违法违规使用医保基金自查自纠工作国家医疗保障局近日在全国范围内组织开展2026年定点医药机构违法违规使用医保基金自查自纠工作。自查自纠聚焦重点领域“逐渐细化、持续深化”。在既往心血管内科、骨科、血液净化、康复、医学影像、临床检验、肿瘤、麻醉、重症医学等9个重点领域的基础上,本年度进一步将口腔、内分泌、精神医学3个领域纳入自查自纠范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705224747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705224747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["002437","02196","600513","NVOH","LU1093756168.USD","BK4599","NVO","LU1093756325.SGD","BK4532","NVOX","300558","301087","REGN","688177","IE00BKVL7J92.USD","603087","BK4588","600196","BK4007","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627420487","title":"诺和诺德全球高级副总裁兼大中国区总裁蔡琰:立足司美原研优势 挑战中寻找更大机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2627420487","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627420487?lang=zh_cn&edition=full","pubTime":"2026-04-15 07:00","pubTimestamp":1776207600,"startTime":"0","endTime":"0","summary":"2026年3月,诺和诺德明星产品司美格鲁肽核心化合物在中国的专利到期。随着这一时间节点的到来,国内多款生物类似药的申报已进入冲刺阶段,市场对这家丹麦制药巨头在华策略的关注度持续升温。“专利到期不是终点。”履新刚满一个月的诺和诺德全球高级副总裁兼大中国区总裁蔡琰博士,在其首场媒体交流活动中给出了明确回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705008845.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705008845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","NVOH","NVO","IE00BZ1G4Q59.USD","BK4532","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","LU0154236417.USD","NVOX","BK4599","BK4588","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627741231","title":"诺和诺德(NVO)单剂量7.2毫克司美鲁肽注射笔获英国药品和健康产品管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2627741231","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627741231?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:57","pubTimestamp":1776160664,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据外媒报道,诺和诺德 公司生产的单剂量7.2毫克司美鲁肽注射笔于当地时间周二正式获得英国药品和健康产品管理局批准。不过,此前要达到这一目标,用户必须每周给自己分三次注射2.4毫克剂量的Wegovy。此番诺和诺德公司7.2毫克装置Wegovy注射笔的获批,实现了用户一次注射即可输送全部剂量。诺和诺德英国公司总经理SebnemAvsarTuna表示:“这种新的单剂量装置的获批为英国每周服用7.2毫克Wegovy维持剂量的人们提供了一种额外的给药选择。”","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299156","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","NVOH","IE00BKVL7J92.USD","BK4599","BK4007","LU1093756168.USD","BK4532","BK4588","NVOX","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":0.0658},{"period":"1month","weight":0.2029},{"period":"3month","weight":-0.2617},{"period":"6month","weight":-0.1128},{"period":"1year","weight":-0.3311},{"period":"ytd","weight":-0.1376}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司,也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦,业务遍及约80个国家,产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018023},{"month":5,"riseRate":0.565217,"avgChangeRate":0.018837},{"month":6,"riseRate":0.688889,"avgChangeRate":0.026171},{"month":7,"riseRate":0.488889,"avgChangeRate":-0.001692},{"month":8,"riseRate":0.533333,"avgChangeRate":0.006145},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}